ArticleCureus2025
Primary Chest Wall Angiofibroma: Expanding the Spectrum of Benign Chest Wall Tumours.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angiofibromas are benign vascular tumours predominantly found in the nasopharynx, with primary chest wall occurrences being exceedingly uncommon. While well-documented in certain anatomical locations like the nasopharynx and facial skin, primary chest wall angiofibromas represent an extremely rare entity with limited information in the medical literature. Management should follow principles for benign but highly vascular chest wall tumours, with comprehensive imaging, cautious biopsy, and complete surgical excision when feasible. Recognising this rarity expands the differential diagnosis of chest wall masses and underscores the importance of documenting atypical sites to improve future diagnosis and management. We report the case of a 62-year-old woman with a symptomatic primary chest wall angiofibroma treated through surgical resection. The patient made an excellent recovery following surgery, which reinforces the clinical importance of identifying rare benign vascular tumours early to guide timely and effective management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.